Downstream Processing Market to Reach $124.7 billion by 2035

Downstream processing market was valued at $40.2 billion in 2025 and is projected to reach $124.7 billion by 2035, growing at a CAGR of 15.9% during the forecast period (2026-2035). The growth of the downstream processing market is being strongly supported by the increasing volume of biologics approvals and the parallel expansion of manufacturing infrastructure. Downstream operations are essential in the purification, concentration, and recovery of biologic products such as monoclonal antibodies, vaccines, plasma-derived therapies, and recombinant proteins. According to the U.S. Food and Drug Administration, 46 novel drug therapies were approved in 2025, including 12 biologics, indicating continued momentum in advanced therapeutics commercialization. The agency also reported that 70% of these therapies were first approved in the United States, highlighting the country’s leadership in innovative drug launches.

Browse the full report description of “Downstream Processing Market Size, Share & Trends Analysis Report by Product Type (Chromatography Systems, Filters, Single-Use Systems, Centrifuges, Evaporators & Dryers, and Accessories & Consumables), by Technique (Solid-Liquid Separation, Purification, and Polishing), by Application (Monoclonal Antibodies, Vaccines, Insulin, Growth Hormones, Blood Plasma Products, Recombinant Proteins, and Cell & Gene Therapy Products), by End-User (Biopharmaceutical Companies, Contract Development & Manufacturing Organizations (CDMOs), and Academic & Research Institutes), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/downstream-processing-market

As commercial production volumes rise, manufacturers are investing in larger and more efficient purification systems, chromatography platforms, membrane filtration units, and single-use downstream technologies. Each newly approved biologic requires validated large-scale purification capacity before market supply can begin, creating direct equipment demand. Expansion by contract development and manufacturing organizations is further strengthening procurement activity across processing lines. Regulatory expectations for purity, sterility, and batch consistency are also encouraging modernization of legacy systems. This combination of rising biologics output, facility investment, and stringent compliance standards continues to position downstream processing as a critical expenditure area within biopharmaceutical manufacturing.

Innovation Leaders Transforming the Downstream Processing Market

The key players in the downstream processing market include Danaher, Sartorius AG, Thermo Fisher Scientific, Merck KGaA, Repligen Corporation, among others.

• In May 2024, Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification.

• In October 2023, SCHOTT introduced the ViewCell flow cell, a new component for biopharmaceutical process analysis. The flow cell is designed to enable safe, continuous process control directly in the production line. According to the company, the innovative process analysis technology (PAT) component acts as a sterile interface between product and optical measurement systems.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Technique
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Danaher, Sartorius AG, Thermo Fisher Scientific, Merck KGaA, Repligen Corporation, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Downstream Processing Market Report Segment

By Product Type

• Chromatography Systems
• Filters
• Single-Use Systems
• Centrifuges
• Evaporators & Dryers
• Accessories & Consumables

By Technique

• Solid-Liquid Separation
• Purification
• Polishing

By Application

• Monoclonal Antibodies
• Vaccines
• Insulin
• Growth Hormones
• Blood Plasma Products
• Recombinant Proteins
• Cell & Gene Therapy Products

By End-User

• Biopharmaceutical Companies
• Contract Development & Manufacturing Organizations (CDMOs)
• Academic & Research Institutes

Global Downstream Processing Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/downstream-processing-market